GAMMATETANOS 250 IU/2 ml, solution for injection (IM) syringe, 2 ml
Active ingredients: IMMUNOGLOBULINE HUMAINE TÉTANIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 2 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GAMMATETANOS 250 UI/2 mL, solution injectable (IM)
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 2 ml avec aiguille(s)
- Marketing authorisation holder
- LFB-BIOMEDICAMENTS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1995
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62136562CIP73289219CIP133400932892198Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMMUNOGLOBULINE HUMAINE TÉTANIQUEsolution | 250 Ul · 2 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.